Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2025-12-25 @ 5:08 AM
NCT ID:
NCT03326427
Eligibility Criteria:
Inclusion Criteria:
* Patients with ADHD
* Medicated with following drugs and minimum daily dosages:
Methylphenidate ≥ 0.5 mg/kg Lisdexamfetamine ≥ 30mg Bupropion ≥ 150 mg Modafinil ≥ 200mg Imipramine ≥ 1mg/kg
* At least one month of stabilized dosage for any psychiatric medication.
* ADHD-Self Report Scale ≥ 20.
* Knowledge of oral and written communication in Portuguese
* IQ\>85 (intelligence quotient)
Exclusion Criteria:
* diagnoses of Borderline or Anti-social personality disorders.
* diagnoses of autism spectrum disorder
* current episode of major depression or suicide toughs
* current episodes of mania or hypomania
* recent episodes of drug abuse (last 6 months)
* diagnoses of drug dependence
* patients that change their medications or their psychiatric conditions in the exclusion criteria above after the beginning of the protocol will have their data censored, but included in the intention to treat analyses. These patients will keep the right to attend all the sessions in the protocol at their discretion.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT03326427
Study Brief:
Protocol Section:
NCT03326427